OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists
Ana Mallo‐Abreu, Rubén Prieto‐Díaz, Willem Jespers, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 14, pp. 7721-7739
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Alchemical Transformations and Beyond: Recent Advances and Real-World Applications of Free Energy Calculations in Drug Discovery
Runtong Qian, Jing Xue, You Xu, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 19, pp. 7214-7237
Closed Access | Times Cited: 7

Computational Workflow for Refining AlphaFold Models in Drug Design Using Kinetic and Thermodynamic Binding Calculations: A Case Study for the Unresolved Inactive Human Adenosine A3 Receptor
Margarita Stampelou, Graham Ladds, Antonios Kolocouris
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 4, pp. 914-936
Closed Access | Times Cited: 5

Synthesis of Substituted α-Carboline Derivatives by Base-Mediated Annulation of Azaindoles with Alkylidene Malononitriles
Venkata Rao Kaki, Aakansha Negi, Harshini Gaddam, et al.
Synlett (2025)
Closed Access

Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets
Kenneth A. Jacobson, Adriaan P. IJzerman, Christa E. Müller
Biochemical Pharmacology (2020) Vol. 187, pp. 114311-114311
Open Access | Times Cited: 35

Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design
Veronica Salmaso, Kenneth A. Jacobson
ChemMedChem (2020) Vol. 15, Iss. 21, pp. 1958-1973
Open Access | Times Cited: 25

A2Badenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
Apple H.M. Tay, Rubén Prieto‐Díaz, Shiyong Neo, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004592-e004592
Open Access | Times Cited: 15

Dihydroazolopyrimidines: Past, Present and Perspectives in Synthesis, Green Chemistry and Drug Discovery
Sergey M. Desenko, Nikolay Yu. Gorobets, В. В. Липсон, et al.
The Chemical Record (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 8

Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists
Rubén Prieto‐Díaz, Manuel Antonio González-Gómez, Hugo Fojo-Carballo, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 890-912
Open Access | Times Cited: 13

Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor
Xianglin Huang, Anna Chorianopoulou, Panagoula Kalkounou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 13117-13146
Open Access | Times Cited: 2

Potent, Selective, and Membrane Permeable 2-Amino-4-Substituted Pyridine-Based Neuronal Nitric Oxide Synthase Inhibitors
Dhananjayan Vasu, Ha T., Huiying Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9934-9953
Closed Access | Times Cited: 6

Identification of V6.51L as a selectivity hotspot in stereoselective A2B adenosine receptor antagonist recognition
Xuesong Wang, Willem Jespers, Rubén Prieto‐Díaz, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 13

Enantioselective Synthesis of Axially Chiral Oxazole Biaryls by Copper‐Catalyzed Oxidation of Cyclic Diaryliodoniums
Daqian Zhu, Yameng Sun, Hui Peng, et al.
European Journal of Organic Chemistry (2022) Vol. 2022, Iss. 9
Closed Access | Times Cited: 9

Discovery of Novel Benzo[4,5]imidazo[1,2-a]pyrazin-1-amine-3-amide-one Derivatives as Anticancer Human A2A Adenosine Receptor Antagonists
Shuhao Liu, Wen Ding, Wei-Feng Huang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 8933-8947
Closed Access | Times Cited: 9

Regioselective synthesis of 3,4-diarylpyrimido[1,2-b]indazole derivatives enabled by iron-catalyzed ring-opening of styrene oxides
Penghui Cao, Guangping Fan, Xiaofei Zhao, et al.
Chemical Communications (2024)
Closed Access | Times Cited: 1

Using sulfate-functionalized Hf-based metal–organic frameworks as a heterogeneous catalyst for solvent-free synthesis of pyrimido[1,2-a]benzimidazoles via one-pot three-component reaction
Minh-Huy Dinh Dang, Linh Hồ Thùy Nguyễn, Trang Nguyen, et al.
Journal of Industrial and Engineering Chemistry (2021) Vol. 103, pp. 340-347
Closed Access | Times Cited: 10

Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists
Cristina Val, Carlos Rodríguez-García, Rubén Prieto‐Díaz, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2091-2106
Open Access | Times Cited: 6

Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A2B adenosine receptor antagonists
Anna Vlachodimou, Henk de Vries, Milena Pasoli, et al.
Biochemical Pharmacology (2022) Vol. 200, pp. 115027-115027
Open Access | Times Cited: 6

Manganese-catalyzed dehydrogenative Csp3–Csp2 coupling of imidazo[1,2-a]pyridines with methyl ketones
Hua Yao, Xiaoyang Zhong, Bingqing Wang, et al.
Organic & Biomolecular Chemistry (2021) Vol. 19, Iss. 15, pp. 3479-3483
Closed Access | Times Cited: 8

In Silico Positional Analogue Scanning with Amber GPU-TI
Yuan Hu, Ingo Muegge
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 18, pp. 4448-4459
Closed Access | Times Cited: 4

Exploring naltrexamine derivatives featuring azaindole moiety via nitrogen-walk approach to investigate their in vitro pharmacological profiles at the mu opioid receptor
Hongguang Ma, Huiqun Wang, James C. Gillespie, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 41, pp. 127953-127953
Open Access | Times Cited: 4

Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase
Isabella Bolognino, Antonio Carrieri, Rosa Purgatorio, et al.
Separations (2021) Vol. 9, Iss. 1, pp. 7-7
Open Access | Times Cited: 4

Discovery of 6α-Thiazolylcarboxamidonaltrexamine Derivative (NTZ) as a Potent and Central Nervous System Penetrant Opioid Receptor Modulator with Drug-like Properties for Potential Treatment of Opioid Use Disorder
Boshi Huang, Hongguang Ma, Piyusha P. Pagare, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 4165-4182
Closed Access

Page 1 - Next Page

Scroll to top